These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 30863781)
1. Pioglitazone Ameliorates Atorvastatin-Induced Islet Cell Dysfunction through Activation of FFA1 in INS-1 Cells. Zhu K; Qian L; Lin Y; An L; Mu G; Ma G; Ren L J Diabetes Res; 2019; 2019():5245063. PubMed ID: 30863781 [TBL] [Abstract][Full Text] [Related]
2. Fetuin A promotes lipotoxicity in β cells through the TLR4 signaling pathway and the role of pioglitazone in anti-lipotoxicity. Shen X; Yang L; Yan S; Zheng H; Liang L; Cai X; Liao M Mol Cell Endocrinol; 2015 Sep; 412():1-11. PubMed ID: 25986658 [TBL] [Abstract][Full Text] [Related]
3. Pioglitazone acutely reduces insulin secretion and causes metabolic deceleration of the pancreatic beta-cell at submaximal glucose concentrations. Lamontagne J; Pepin E; Peyot ML; Joly E; Ruderman NB; Poitout V; Madiraju SR; Nolan CJ; Prentki M Endocrinology; 2009 Aug; 150(8):3465-74. PubMed ID: 19406947 [TBL] [Abstract][Full Text] [Related]
4. Linoleic acid activates GPR40/FFA1 and phospholipase C to increase [Ca2+]i release and insulin secretion in islet beta-cells. Zhou YJ; Song YL; Zhou H; Li Y Chin Med Sci J; 2012 Mar; 27(1):18-23. PubMed ID: 22734209 [TBL] [Abstract][Full Text] [Related]
5. Hepatitis B X-interacting protein promotes the formation of the insulin gene-transcribing protein complex Pdx-1/Neurod1 in animal pancreatic β-cells. Li H; Wang Z; Li Y; Fang R; Wang H; Shi H; Zhang X; Zhang W; Ye L J Biol Chem; 2018 Feb; 293(6):2053-2065. PubMed ID: 29259128 [TBL] [Abstract][Full Text] [Related]
6. The relationship between GPR40 and lipotoxicity of the pancreatic β-cells as well as the effect of pioglitazone. Wu P; Yang L; Shen X Biochem Biophys Res Commun; 2010 Dec; 403(1):36-9. PubMed ID: 21036144 [TBL] [Abstract][Full Text] [Related]
7. In vitro and mouse in vivo characterization of the potent free fatty acid 1 receptor agonist TUG-469. Urban C; Hamacher A; Partke HJ; Roden M; Schinner S; Christiansen E; Due-Hansen ME; Ulven T; Gohlke H; Kassack MU Naunyn Schmiedebergs Arch Pharmacol; 2013 Dec; 386(12):1021-30. PubMed ID: 23861168 [TBL] [Abstract][Full Text] [Related]
8. Atorvastatin Targets the Islet Mevalonate Pathway to Dysregulate mTOR Signaling and Reduce β-Cell Functional Mass. Shen L; Gu Y; Qiu Y; Cheng T; Nie A; Cui C; Fu C; Li T; Li X; Fu L; Wang Y; Ni Q; Wang Q; Wang W; Feng B Diabetes; 2020 Jan; 69(1):48-59. PubMed ID: 31649162 [TBL] [Abstract][Full Text] [Related]
9. Activity of dietary fatty acids on FFA1 and FFA4 and characterisation of pinolenic acid as a dual FFA1/FFA4 agonist with potential effect against metabolic diseases. Christiansen E; Watterson KR; Stocker CJ; Sokol E; Jenkins L; Simon K; Grundmann M; Petersen RK; Wargent ET; Hudson BD; Kostenis E; Ejsing CS; Cawthorne MA; Milligan G; Ulven T Br J Nutr; 2015 Jun; 113(11):1677-88. PubMed ID: 25916176 [TBL] [Abstract][Full Text] [Related]
10. Rosiglitazone stimulates the release and synthesis of insulin by enhancing GLUT-2, glucokinase and BETA2/NeuroD expression. Kim HS; Noh JH; Hong SH; Hwang YC; Yang TY; Lee MS; Kim KW; Lee MK Biochem Biophys Res Commun; 2008 Mar; 367(3):623-9. PubMed ID: 18191635 [TBL] [Abstract][Full Text] [Related]
11. Islet neogenesis-associated protein (INGAP)-positive cell mass, β-cell mass, and insulin secretion: their relationship during the fetal and neonatal periods. Madrid V; Borelli MI; Maiztegui B; Flores LE; Gagliardino JJ; Zotto HD Pancreas; 2013 Apr; 42(3):422-8. PubMed ID: 23303201 [TBL] [Abstract][Full Text] [Related]
12. Combination of MafA, PDX-1 and NeuroD is a useful tool to efficiently induce insulin-producing surrogate beta-cells. Kaneto H; Matsuoka TA; Katakami N; Matsuhisa M Curr Med Chem; 2009; 16(24):3144-51. PubMed ID: 19689288 [TBL] [Abstract][Full Text] [Related]
13. The P21-activated kinase PAK4 is implicated in fatty-acid potentiation of insulin secretion downstream of free fatty acid receptor 1. Bergeron V; Ghislain J; Poitout V Islets; 2016 Nov; 8(6):157-164. PubMed ID: 27700527 [TBL] [Abstract][Full Text] [Related]
14. Atorvastatin inhibits insulin synthesis by inhibiting the Ras/Raf/ERK/CREB pathway in INS-1 cells. Sun H; Li Y; Sun B; Hou N; Yang J; Zheng M; Xu J; Wang J; Zhang Y; Zeng X; Shan C; Chang B; Chen L; Chang B Medicine (Baltimore); 2016 Sep; 95(39):e4906. PubMed ID: 27684825 [TBL] [Abstract][Full Text] [Related]
15. miRNA-30a-5p-mediated silencing of Beta2/NeuroD expression is an important initial event of glucotoxicity-induced beta cell dysfunction in rodent models. Kim JW; You YH; Jung S; Suh-Kim H; Lee IK; Cho JH; Yoon KH Diabetologia; 2013 Apr; 56(4):847-55. PubMed ID: 23338554 [TBL] [Abstract][Full Text] [Related]
16. Distinct effects of pravastatin, atorvastatin, and simvastatin on insulin secretion from a beta-cell line, MIN6 cells. Ishikawa M; Okajima F; Inoue N; Motomura K; Kato T; Takahashi A; Oikawa S; Yamada N; Shimano H J Atheroscler Thromb; 2006 Dec; 13(6):329-35. PubMed ID: 17192698 [TBL] [Abstract][Full Text] [Related]
17. [Research on the effect of statins on insulin secretion from pancreatic islet in rats and its mechanisms]. Chang BC; Zheng MY; Shan CY; Yang JH; Wang Y; Ren HZ; Chen LM; Fang PH Zhonghua Nei Ke Za Zhi; 2011 May; 50(5):393-6. PubMed ID: 21624221 [TBL] [Abstract][Full Text] [Related]
18. Pioglitazone/metformin adduct regulates insulin secretion and inhibits high glucose-induced apoptosis via p21-p53-MDM2 signaling in INS-1 cells. Liu RX; Ma Y; Hu XL; Liao YP; Hu XN; He BC; Sun WJ J Cell Biochem; 2018 Jul; 119(7):5449-5459. PubMed ID: 29369427 [TBL] [Abstract][Full Text] [Related]
19. Expression of fatty acid binding proteins 3 and 5 genes in rat pancreatic islets and INS-1E cells: regulation by fatty acids and glucose. Hyder A; Zenhom M; Klapper M; Herrmann J; Schrezenmeir J Islets; 2010; 2(3):174-84. PubMed ID: 21099311 [TBL] [Abstract][Full Text] [Related]
20. Interactions between Atorvastatin and the Farnesoid X Receptor Impair Insulinotropic Effects of Bile Acids and Modulate Diabetogenic Risk. Hoffmeister T; Kaiser J; Lüdtke S; Drews G; Düfer M Mol Pharmacol; 2020 Mar; 97(3):202-211. PubMed ID: 31911428 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]